Skip to main content
Caplight Logo









UE LifeSciences

UE LifeSciences

Private
Philadelphia, PennsylvaniaHealthcare & Life Scienceshttps://www.uelifesciences.com/

Last Round

Grant

Aug 20, 2019

Total Funding Raised

$5.43M

Company Overview

UE LifeSciences is a medical technology company that develops non-invasive, portable diagnostic devices for early cancer detection, particularly for underserved populations.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Medical Imaging, Medical AI, Health IoT

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Application

Keywords

medical diagnostic devicepoint-of-care diagnosticsbreast cancer screeningcervical cancer screeningmedical AImedtechAI-enabled diagnosticsportable medical devicehealth technon-invasive screeningfemtechdigital healthglobal health technologytelemedicinehealth equity

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

UE LifeSciences Comparables

Compare UE LifeSciences with similar companies based on industry and business-model similarity.

UE LifeSciences comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Bexa, Inc.
86%
Niramai Health Analytix
83%
Salva Health
81%

UE LifeSciences Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantAug 20, 2019
StrategicOct 4, 2016
Series ASep 14, 2015
GrantMay 21, 2015
GrantAug 20, 2012

UE LifeSciences Investors

Notable investors and investment history

UE LifeSciences investors
InvestorRounds
The Pfizer FoundationGrant
Aarin Capital PartnersSeries A
Pennsylvania Department of HealthGrant
Capria VenturesStrategic, Series A, Grant
Bayer Cares FoundationGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Sep 14, 2015

    $3M round led by Aarin Capital Partners

  • Aug 20, 2012

    $878K grant received from Pennsylvania Department of Health.

UE LifeSciences Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

UE LifeSciences Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about UE LifeSciences's valuation, stock price, and market status.

Firmographic Details

HeadquartersPhiladelphia, Pennsylvania
Employee Range66
Year Founded2009
Last FundingAug 20, 2019

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?